Cure Pharmaceutical Holding Corp (OTCMKTS:CURR) Stock On Watchlist After Q2 Earnings

September 6, 2022

Proprietary wellness technology, Cure Pharmaceutical Holding Corp (OTCMKTS:CURR), on September 2, 2022, announced results for the quarter ending June 30, 2022. Trading Data On Friday, CURR stock decreased 0.04% to $0.2799 with more than 41.93K shares, compared to its average volume of 124.85K shares. The stock moved within a range of $0.2600 – 0.2940 after opening trading at $0.2940. Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues…


Cure Pharmaceutical (OTCMKTS:CURR) Stock Extends Fall: Company Collaborates With Milagro Pharmaceuticals

March 7, 2022

Shares of Cure Pharmaceutical (OTCMKTS:CURR) continues to trend lower on Friday and fell 29% last week. Trading Data On Friday, CURR stock went down 9.10% to $0.25 with more than 187K shares traded, compared to its average volume of 170K shares. The stock moved within a range of $0.2300 – 0.2587 after opening trading at $0.24. CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin…